Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcioz-CT is a branded generic nutritional supplement combination developed and marketed by Chemross Lifesciences. It is typically formulated as a softgel capsule containing calcium carbonate, calcitriol (the active form of vitamin D3), and zinc. The product is indicated for the management of calcium deficiency and bone-related conditions such as osteoporosis, osteomalacia, and rickets. Calcitriol acts as a Vitamin D receptor agonist to increase intestinal calcium absorption, while calcium carbonate provides a source of elemental calcium for bone mineralization. Zinc serves as a mineral cofactor supporting bone metabolism and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium carbonate + calcitriol + zinc.